Pathophysiological basis of acute inflammatory hyperaemia in the rat knee: Roles of cyclo-oxygenase-1 and -2

Journal of Physiology

Volumn 539, Issue 2, 2002, Pages 579-587

  Egan, Colin G ^a   Lockhart, John C ^a   Ferrell, William R ^b   Day, Suzanne M ^a   McLean, John S ^a  

^a UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; CARRAGEENAN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DRUG VEHICLE; INDOMETACIN; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ENZYME ACTIVITY; ENZYME INDUCTION; HYPEREMIA; INFLAMMATORY DISEASE; KNEE; LASER DOPPLER FLOWMETRY; MALE; METABOLITE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROSTAGLANDIN URINE LEVEL; RAT; STATISTICAL ANALYSIS; SYNOVIUM; VASCULAR RESISTANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ENZYME ANALYSIS; GENE EXPRESSION; INFLAMMATION; KNEE DISEASE; PROTEIN EXPRESSION; TISSUE BLOOD FLOW;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CARRAGEENAN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; EDEMA; HINDLIMB; HYPEREMIA; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOENZYMES; LASER-DOPPLER FLOWMETRY; MALE; MEMBRANE PROTEINS; NITRATES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; OSMOLAR CONCENTRATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0036521876     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2001.013473     Document Type: Article

References (52)

1. ABBOT, N. C., FERRELL, W. R., LOCKHART, J. C. & LOWE, J. G. (1996). Laser Doppler imaging of skin blood flow using red and near-infrared sources. Journal of Investigative Dermatology 107, 882-886.
2. COOKE, L P. & TSAO, P. S. (1993). Cytoprotective effects of nitric oxide (Editorial). Circulation 88, 2451-2454.
3. CROFFORD, L. J. (1996). Expression and regulation of COX-2 in synovial tissues of arthritis patients. In Improved Non-steroid Anti-inflammatory Drugs: COX-2 Enzyme Inhibitors, ed. VANE, J., BOTTING, J. & BOTTING, R., pp. 133-143. Kluwer Academic Publishers and William Harvey Press, London.
4. CROFFORD, L. J., WILDER, R. L., RISTIMAKI, A. P., REMMERS, E. F., EPPS, H. R. & HLA, T. (1994). Cyclooxygenase- I and -2 expression in rheumatoid synovial tissues: effects of interleukin- 1,β, phorbal ester, and corticosteroids, Journal of Clinical Investigation 93, 1095-1101.
5. DAVIES, P. & MACINTYRE, D. E. (1992). Prostglandins and inflammation. In Inflammation: BasicPrinciples and Clinical Correlates, ed. GALLIN, J. L, GOLDSTEIN, I. M. & SNYDERMAN, R., pp. 123-137. Raven Press Ltd, New York.
6. DAVIS, B. J., LENNARD, D. E., LEE, C. A., TIANO, H. F., MORHAM, S. G., WETSEL, W. C. & LANGENBACH, R. (1999). Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E, and interleukin- 1,β. Endocrinology 140, 2685-2695.
7. DELA TORRE, A., SCHROEDER, R. A. & KUO, P. C. (1997). Alteration of NF-kappa B P50 binding kinetics by S-nitrosylation. Biochemical and Biophysical Research Communications 238, 703-706.
8. DI ROSA, M. & WILLOUGHBY, D. A. (1971). Screens for anti-inflammatory drugs. Journal of Pharmacy and Pharmacology 23, 297-298.
9. DIXON, D. A., KAPLAN, C. D., MCINTYRE, T. M., ZIMMERMAN, G. A. & PRESCOTT, S. M. (2000). Post -transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region. Journal of Biological Chemistry 275, 11750-11757.
10. EGAN, C. G., LOCKHART, J. C., MCLEAN, J. S. & FERRELL, W. R. (2001). Expression of constitutive but not inducible cyclooxygenase maintains articular perfusion in the rat knee. Experimental Physiology 86, 191-197.
11. ERMERT, L., ERMERT, M., GoPPELT-STRUEBE, M., WALMRATH, D., GRIMMINGER, F., STEUDEL, W., GHOFRANI, H. A., HOMBERGER, C., DUNCKER, H. & SEEGER, W. (1998). Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs. American Journal ofRespiratory Cell and Molecular Biology 18, 479-488.
12. FELDMANN, M. & MAINI, R. N. (1999). The role of cytokines in the pathogenesis of rheumatoid arthritis. Rheumatology 38 (suppl. 2), 3-7.
13. FERRELL, W. R., BALINT, P. V., EGAN, C. G., LOCKHART, J. C. & STURROCK, R. D. (2001). Metacarpophalangeal joints in rheumatoid arthritis: laser Doppler imaging - initial experience. Radiology 220, 257-262.
14. FRIES, J. F. (1999). How may quality of life for rheumatoid arthritis patients be enhanced by current and future treatments? Rheumatology 38 (suppl. 2), 35-40.
15. GIERSE, J. K., MCDONALD, J. J., HAUSER, S. D., RANGWALA, S. H., KOBOLDT, C. M. & SEIBERT, K. (1996). A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors. Journal of Biological Chemistry 271, 15810-15814.
16. GILROY, D. W., COLVILLE-NASH, P. R., WILLIS, D., CHIVERS, J., PAUL-CLARK, M. J. & WILLOUGHBY, D. A. (1999). Inducible cyclooxygenase may have anti- inflammatory properties. Nature Medicine 5, 698-701.
17. GORBUNOV, N. & ESPOSITO, E. (1993). Nitric oxide as a mediator of inflammation. International Journal of Immunopathology and Pharmacology 6,67-75.
18. GOU, Q., LIU, C. H., BEN-AV, P. & HLA, T. (1998). Dissociation of basal turnover and cytokine-induced transcript stabilisation of the human cyclooxygenase-2 mRNA by mutagenesis of the 3′-untranslated region. Biochemical and Biophysical Research Communications 242, 508-512.
19. GRABOWSKI, P. S., ENGLAND, A. J., DYKHUIZEN, R., COPLAND, M., BENJAMIN, N., REID, D. M. & RALSTON, S. H. (1996). Elevated nitric oxide production in rheumatoid arthritis. Detection using the fasting urinary nitrate: creatinine ratio. Arthritis and Rheumatism 39, 643-647.
20. GROSS, G., IMAMURA, T., VOGT, S. K., WOZNIAK, D. F., NELSON, D. M., SADOVSKY, Y. & MUGLIA, L. J. (2000). Inhibition of cyclooxygenase-2 prevents inflammation-mediated preterm labor in the mouse. American Journal of Physiology - Regulatory Integrative and Comparative Physiology 278, R1415-1423.
21. HARRIS, R. C., MCKANNA, J. A., AKAI, Y., JACOBSON, H. R., DUBOIS, R. N. & BREYER, M. D. (1994). Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. Journal of Clinical Investigation 94, 2504-2510.
22. HAWKEY, C. J. (1999). COX-2 inhibitors. Lancet 353, 307-314.
23. JANG, D. & MURRELL, G. A. (1998). Nitric oxide in arthritis. Free Radical Biology and Medicine 24, 1511-1519.
24. KANG, R. Y., FREIRE-MOAR, J., SIGAL, E. & CHU, C.-Q. (1996). Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis. British Journal of Rheumatology 35, 711-718.
25. KENNEDY, T. A., SMITH, C. J. & MARNETT, L. J. (1994). Investigations of the roles of cysteines in catalysis by prostaglandin endoperoxide synthase. Journal of Biological Chemistry 269, 27357-27364.
26. KOMHOFF, M., WANG, J. L., CHENG, H. F., LANGENBACH, R., MCKANNA, J. A., HARRIS, R. C. & BREYER, M. D. (2000). Cyclooxygenase-2 -selective inhibitors impair glomerulogenesis and renal cortical development. Kidney International 57, 414-422.
27. LAM, F. Y. & FERRELL, W. R. (1993). Acute inflammation in the rat knee joint attenuates sympathetic vasoconstriction but enhances neuropeptide- mediated vasodilatation assessed by laser Doppler perfusion imaging. Neuroscience 52, 443-449.
28. LANGENBACH, R., MORHAM, S. G., TIANO, H. F., LOFTIN, C. D., GHANAYEM, B. L, CHULADA, P. C., MAHLER, J. F., LEE, C. A., GOULDING, E. H. & KLUCKMAN, K. D. (1995). Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83, 483-492.
29. LEVICK, J. R. (1984). Blood flow and mass transport in synovial joints. In Handbook ofPhysiology, The Cardiovascular System, vol. IV, The Microcirculation, ed. RENKIN, E. M. & MICHEL, C. C., pp. 917-947. American Physiological Society, Bethesda.
30. LIM, H., PARIA, B. C., DAS, S. K., DINCHUK, J. E., LANGENBACH, R., TRZASKOS, J. M. & DEY, S. K. (1997). Multiple female reproductive failures in cyclooxygenase 2 -deficient mice. Cell 91, 197-208.
31. LOCKHART, J. C. & FERRELL, W. R. (2000). Attenuation of joint inflammation by selective iNOS inhibitors. Nitric oxide: Biology and Chemistry 4, 321 (abstract).
32. MCKIBBIN, B. & MAROUDAS, A. (1979). Nutrition and metabolism. In Adult Articular Cartilage, ed. FREEMAN, M. A. R., pp. 461-468. Pitman Medical, Tunbridge Wells, UK.
33. MALMBERG, A. B. & YAKSH, T. L. (1992). Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science 257, 1276-1279.
34. MIRANDA, K. M., ESPEY, M. G. &WINK, D. A. (2000). A rapid, simple spectrophotometric method for detection of nitrate and nitrite. Nitric Oxide: Biology and Chemistry 4, 274 (abstract).
35. MITCHELL, J. A., LARKIN, S. & WILLIAMS, T. J. (1995). Cyclooxygenase-2: regulation and relevance in inflammation. Biochemical Pharmacology 50, 153 5-1542.
36. MONCADA, S., PALMER, R. M. & HIGGS, E. A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 43, 109-142.
37. NAJAFIPOUR, H. & FERRELL, W. R. (1994). Role of prostaglandins in regulation of blood flow and modulation of sympathetic vasoconstriction in normal and acutely inflamed rabbit knee joints. Experimental Physiology 79, 93-103.
38. NAJAFIPOUR, H. & FERRELL, W. R. (1995). Comparison of synovial P02 and sympathetic vasoconstrictor responses in normal and acutely inflamed rabbit knee joints. Experimental Physiology 80, 209-220.
39. NANTEL, F., DENIS, D., GORDON, R., NORTHEY, A., CIRINO, M., METTERS, K. M. & CHAN, C. C. (1999). Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation. British Journal of Pharmacology 128, 853-859.
40. SALVEMINI, D., MANNING, P. T., ZWEIFEL, B. S., SEIBERT, K., CONNOR, J., CURRIE, M. G., NEEDLEMAN, P. & MASFERRER, J. L. (1995). Dual inhibition of nitric oxide and prostaglandin production contributes to the anti -inflammatory properties of nitric oxide synthase inhibitors. Journal of Clinical Investigation 96, 301-308.
41. SALVEMINI, D., MISKO, T. P., MASFERRER, J. L., SEIBERT, K., CURRIE, M. G. & NEEDLEMAN, P. (1993). Nitric oxide activates cyclooxygenase enzymes. Proceedings of the National Academy of Sciences of the USA 90, 7240-7244.
42. SALVEMINI, D., WANG, Z.-Q., WYATT, P. S., BOURDON, D. M., MARINO, M. FL, MANNING, P. T. & CURRIE, M. G. (1996). Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. British Journal of Pharmacology 118, 829-838.
43. SANO, H., HLA, T., MAIER, J. A. M., CROFFORD, L. J., CASE, J. P., MACIAG, T. & WILDER, R. L. (1992). In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. Journal of Clinical Investigation 89, 97-108.
44. SANTER, V., SRIRTANA, A. & LOWTHER, D. A. (1983). Carrageenin-induced arthritis. V. A. morphological study of the development of inflammation. Seminars in Arthritis and Rheumatism 13, 160-168.
45. STADLER, J., STEFANOVIC-RACIC, M., BILLIAR, T. R., CURRAN, R. D., MCINTYRE, L. A., GEORGESCU, H. L, SIMMONS, R. L. & EVANS, C. H. (1991). Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. Journal of Immunology 147, 3915-3920.
46. STICHTENOTH, D. O. & FRÖLICH, J. C. (1998). Nitric oxide and inflammatory diseases. British Journal of Pharmacology 37, 246-257.
47. SWI ERKOSZ, T. A., MITCHELL, J. A., WARNER, T. D., BOTTING, R. M. &VANE, J. R. (1995). Co-induction of nitric oxide between nitric oxide and prostanoids. British Journal of Pharmacology 114, 1335-1342.
48. TOMLINSON, A., APPLETON, L, MOORE, A. R., GILROY, D. W., WILLIS, D., MITCHELL, J. A. &WILLOUGHBY, D. A. (1994). Cyclooxygenase and nitric oxide synthase isoforms in rat carrageenininduced pleurisy. British Journal of Pharmacology 113, 693-698.
49. VANE, J. (1994). Towards a better aspirin. Nature 367, 215-216.
50. WALLACE, J. L., BAK, A., MCKNIGHT, W., AsFAHA, S., SHARKEY, K. A. & MACNAUGHTON, W. K. (1998). Cyclooxygenase I contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity [see comments]. Gastroenterology 115, 101-109.
51. WALLACE, J. L., CHAPMAN, K. & MCKNIGHT, W. (1999). Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation. British Journal of Pharmacology 126, 1200-1204.
52. YANG, T., SINGH, L, PHAM, H., SUN, D., SMART, A., SCHNERMANN, J. B. & BRIGGS, J. P. (1998). Regulation of cyclooxygenase expression in the kidney by dietary salt intake. American Journal of Physiology 274, F481-489.